Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04818827 · ClinicalTrials.gov registry record

Ketamine Infusion as Sedative Analgesic in Severe ARDS

A clinical trial of Delirium and Mechanical Ventilation Complication, sponsored by Interfaith Medical Center.

Completed
Registry status
124
Enrollment target
1
Study location

NCT04818827 is a study of Delirium and Mechanical Ventilation Complication that has completed, run by Interfaith Medical Center. The registered enrollment target is 124 participants, below the 886-participant average among 62 other Delirium trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04818827, a study of Delirium and Mechanical Ventilation Complication, has completed, sponsored by Interfaith Medical Center.

COMPLETED
Registry status
124 participants
Enrollment target
1
Study location

Study Summary

To evaluate whether ketamine is a safe sedative-analgesic agent to be used in an intensive care unit (ICU) setting as compared to traditionally used agents such as propofol, opioids, and midazolam

Study Locations (1)

New York

  • Interfaith Medical Center - New York

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2020-02-01
Est. Completion 2021-02-14

Sponsor

Interfaith Medical Center

1 total trials

What the Registry Record Tells You About NCT04818827

The ClinicalTrials.gov registry entry for NCT04818827 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 886-participant average among 62 other Delirium trials with a reported enrollment target (86% lower). The listed sponsor is Interfaith Medical Center, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Delirium appearing as the primary indexed condition, and to 0 interventions.

NCT04818827 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04818827 about?

NCT04818827 is a clinical study titled "Ketamine Infusion as Sedative Analgesic in Severe ARDS". To evaluate whether ketamine is a safe sedative-analgesic agent to be used in an intensive care unit (ICU) setting as compared to traditionally used agents such as propofol, opioids, and midazolam

What is the current status of trial NCT04818827?

This trial is currently completed. The enrollment target is 124 participants. The study started on 2020-02-01. Estimated completion is 2021-02-14.

What conditions does trial NCT04818827 study?

This clinical trial studies the following conditions: Delirium, Mechanical Ventilation Complication, Intensive Care Unit Syndrome, Sedatives and Hypnotics Causing Adverse Effects in Therapeutic Use.

Who is sponsoring clinical trial NCT04818827?

This trial is sponsored by Interfaith Medical Center, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04818827 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.